Health Condition 1: H90- Conductive and sensorineural hearing loss Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Intervention1: Intravenous Dexmedetomidine: The child will receive IV dose of 0.5 mcg/kg of Dexmedetomidine infusion made to a volume of 20 ml by using normal saline over 10 minutes before extubation.
Sponsors
All India Institute Of Medical Sciences AIIMS Jodhpur
Eligibility
Inclusion criteria
Inclusion criteria: Paediatric patients belonging to the group of ASA I/II and in the age group of 1-7 years scheduled to undergo cochlear implant surgery.
Exclusion criteria
Exclusion criteria: 1. ASA III/IV 2. Refusal of the consent by the parents/guardians. 3. Patients with known hypersensitivity to any of the study drugs. 4. Patients with history of motion sickness who are receiving antiemetic drugs before surgery. 5. Patients on medications with antiemetic properties
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare Dexmedetomidine and Clonidine for reducing Post operative nausea vomiting in children undergoing cochlear implant surgery. Timepoint: Immediate Post op - Recovery at 0 min, 15 min and 30 min | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate emergence delirium using the PAED scale and postoperative pain using the FLACC scale. 2. To assess the need for rescue antiemetic administration. 3. To monitor and document complications such as hypotension and bradycardia. Timepoint: Immediate Post op - Recovery at 0 min, 15 min and 30 min | — |
Countries
India
Contacts
Public ContactShilpa Goyal
Department of Anaesthesiology and Critical Care, AIIMS Jodhpur
Outcome results
None listed